Moderna Biotechnology Company has announced that their Covidc-19 vaccine was 90 percent effective six months after a person receives their second dose.

“Vaccine efficacy starting two weeks following the second dose and based on the updated adjudicated cases remains consistent with prior updates, including greater than 90% against all cases of COVID-19, and greater than 95% against severe cases of COVID-19,” the company announced.

Moderna said that new results from a preclinical study of the Company's COVID-19 variant-specific vaccine candidates showed that the Company's variant-specific booster vaccine candidates (mRNA-1273.351 and mRNA-1273.211) increase neutralizing titers against SARS-CoV-2 variants of concern. To date, the Company has delivered approximately 132 million doses of the Moderna COVID-19 Vaccine globally.

“The Moderna team continues to make important progress with our COVID-19 Vaccine,” Stéphane Bancel, CEO of Moderna, said. “The new preclinical data on our variant-specific vaccine candidates give us confidence that we can proactively address emerging variants.” The study includes data from 900 coronavirus cases with over 100 of the cases being severe.

Pakistan claims, will develop single-dose corona vaccine

Corona is attacking 8 times more on vaccinators! Claim in Study

British PM says, 'It is Lockdown, not vaccine rollout, behind the decline in UK's Covid cases'